| Kaileigh Mariah Nightingale, NP | |
|
801 Massachusetts Ave, Crosstown Building Ste 6a, Boston, MA 02118-1020 | |
| (617) 414-5951 | |
| (617) 414-9201 |
| Full Name | Kaileigh Mariah Nightingale |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 801 Massachusetts Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083399984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | RN2318036 (Massachusetts) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | RN2318036 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kaileigh Mariah Nightingale, NP 960 Massachusetts Ave Ste 2, Boston, MA 02118-2690 Ph: () - | Kaileigh Mariah Nightingale, NP 801 Massachusetts Ave, Crosstown Building Ste 6a, Boston, MA 02118-1020 Ph: (617) 414-5951 |
News Archive
Rodman & Renshaw Capital Group, Inc. announced today that its affiliate, Aceras BioMedical LLC (Aceras), has sold Huxley Pharmaceuticals Inc. (Huxley), a portfolio company, to BioMarin Pharmaceutical Inc. (NASDAQ: BMRN). Huxley was established by Aceras in August 2008 with a focus on developing therapeutic products for rare diseases of the nervous system.
Loyola University Medical Center is conducting a clinical trial of an innovative vaccine that could offer hope to patients with advanced ovarian cancer.
The National P4P Summit is a must attend event with national health care leaders addressing today's critical health care issues
New evidence published today highlights benefits and harms of using artificial mesh when compared with tissue repair in the surgical treatment of vaginal prolapse. Slightly better repair with mesh needs to be weighed carefully against increased risk of harms.
Yesterday, the Food and Drug Administration (FDA) issued Bausch & Lomb a report detailing its observations at the conclusion of the inspection of the Greenville, SC plant and a related facility as part of an investigation into a recent increase in Fusarium keratitis infections associated with contact lens wearers using the ReNu with MoistureLoc contact lens cleaning solution.
› Verified 6 days ago